Author:
Publisher:
ISBN: 9781637005255
Category :
Languages : en
Pages : 0
Book Description
PROFILES OF ILLINOIS (2023).
Illinois County Profiles
Author: Illinois. Department of Commerce and Community Affairs
Publisher:
ISBN:
Category : Illinois
Languages : en
Pages : 210
Book Description
Publisher:
ISBN:
Category : Illinois
Languages : en
Pages : 210
Book Description
Profiles of Illinois Business Leaders
Profiles of Change
Author: R.L. Polk & Co. Urban Statistical Division
Publisher:
ISBN:
Category : Cities and towns
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category : Cities and towns
Languages : en
Pages :
Book Description
Profiles of Illinois
Author: Grey House Publishing
Publisher: Profiles of Illinois
ISBN: 9781592377732
Category : Social Science
Languages : en
Pages : 0
Book Description
Profiles of Illinois goes beyond Census statistics, beyond metro area coverage, beyond the 100 best places to live. Drawn from official census information, other government statistics and original research, you will have at your fingertips data that's ava
Publisher: Profiles of Illinois
ISBN: 9781592377732
Category : Social Science
Languages : en
Pages : 0
Book Description
Profiles of Illinois goes beyond Census statistics, beyond metro area coverage, beyond the 100 best places to live. Drawn from official census information, other government statistics and original research, you will have at your fingertips data that's ava
Profiles of Illinois
Author: David Garoogian
Publisher:
ISBN: 9781592371488
Category : History
Languages : en
Pages : 706
Book Description
Publisher:
ISBN: 9781592371488
Category : History
Languages : en
Pages : 706
Book Description
Illinois Community Profile
MULTAQ Drug Profile, 2023
Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 193489995X
Category : Medical
Languages : en
Pages : 73
Book Description
Publisher: DrugPatentWatch.com
ISBN: 193489995X
Category : Medical
Languages : en
Pages : 73
Book Description
MULTAQ Drug Profile, 2023
This report focuses on MULTAQ and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources